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ABSTRACT 
 
Objective: Atrial fibrillation (AF) remains the most commonly observed complication 
following myocardial revascularization surgery. We aimed to evaluate the clinical utility of 
NT-pro-BNP, troponin T, transcoronary lactate gradient (TCLG) and C-reactive protein as 
predictors of atrial fibrillation in patients undergoing isolated CABG. 
Methods: Two hundred and fifteen consecutive patients in sinus rhythm (SR) undergoing 
elective CABG between May 2007 and May 2008 were included. Patients were grouped 
according to their respective postoperative rhythm into SR and AF groups. The data are 
presented as mean values ± standard deviation, or medians with quartiles. 
Results:  Fifty five patients developed AF (26%). The preoperative NT-pro-BNP values were 
273 ± 347 and 469 ± 629 pg/ml in the SR and AF groups, respectively (p < 0.0001). The 
postoperative NT-pro-BNP values were 3110 ± 3600 in the SR and 4625 ± 5640 pg/ml in the 
AF group (p = 0.027). The transcoronary lactate gradient rose from the pre-cardiopulmonary 
bypass (CPB) values to those observed 5 minutes after revascularization in both groups (-0.05 
± 0.37 to 0.39 ± 0.46 mmol/l (p < 0.0001) in the SR group and -0.01 ± 0.27 to 0.43 ± 0.46 
mmol/l (p < 0.0001) in the AF group). The CRP values increased from 6 ± 13 to 163 ± 88 
mg/L (p <  0.0001) in the SR group, and from 6 ± 16 to 163 ± 104 mg/l (p <  0.0001) in the 
AF group. The dynamics of TCLG and CRP did not differ between the groups (p = 0.71, p = 
0.44, respectively). The troponin T values on postoperative day one were significantly higher 
in the AF than the SR group (0.86 [0.49-2.1] ng/ml vs. 0.67 [0.37-1.16] ng/ml, p = 0.046). 
The duration of cardiopulmonary bypass (CPB) was 85 ± 24 in the SR and 93 ± 30 min in the 
AF group (p = 0.05). Patients who developed AF were older (66 ± 7 vs 60 ± 9 years, p <  
0.0001) and had a higher EuroSCORE (3.9 ± 2.7 vs 2.9 ± 2.2, p = 0.009). Multivariate 
analysis identified age (p = 0.0043), preoperative NT-pro-BNP (p = 0.019) and duration of 
cardiopulmonary bypass (p = 0.035) as independent predictors of AF. 
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Conclusions: Preoperative and postoperative NT-pro-BNP, as well as, TnT values were 
significantly higher in patients that subsequently developed AF. TCLG and CRP were not 
useful in identifying patients at higher risk for AF. Multivariate analysis identified age, 
preoperative NT-pro-BNP and duration of CPB as independent correlates of AF.  
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INTRODUCTION 
 
Atrial fibrillation (AF) remains a frequent complication after coronary artery bypass surgery 
(CABG), occurring in 10-40% of patients (1,2,3). Notably, the recruitment of older patients 
into the contemporary cardiac surgical referral pattern is reflected by an increasing incidence 
of postoperative AF (1,4). Atrial fibrillation may present as a benign and self limiting 
disorder. Conversely, it may have a significant adverse impact on patient recovery because 
of its association with hemodynamic compromise, renal insufficiency, prolonged 
requirement for ventilatory support and stroke (3,5). It is also responsible for a longer 
hospital length of stay and, predictably, cost of care (2, 6). The clinical sequelae of AF 
combined with the increased utilization of resources have motivated the definition of various 
algorithms aimed to identify patients at higher risk for developing this complication. 
Uncompromising AF prophylaxis in the higher risk subpopulation of CABG patients could 
reduce cost and improve the postoperative patient recovery. 
The pathogenesis of postoperative AF is multifactorial and may be linked to age, 
intraoperative manipulation with the heart, ischemia, atrial distension, inflammation and 
structural heart disease (2,7). C-reactive protein (CRP) is an acute-phase protein which has 
been effective in defining the degree of inflammation, and was used for that purpose in this 
study (7). Increased CRP levels have been linked to the severity of atherosclerosis, risk of 
coronary events and even long term outcome after CABG (8,9). The mechanism of its 
arrhythmogenesis has been postulated to be related to sodium and calcium exchange 
disturbances following its linkage to phosphocoline (7). A sympathovagal imbalance 
coupled with beta blocker withdrawal has also been postulated to be associated with new 
onset AF (2,3). 
Ischemia may be responsible for an inhomogeneous distribution of local atrial refractoriness 
(10). This dispersion of refractory periods within adjacent atrial regions provides a suitable 
milieu for the development of reentry arrhythmias (10). In the present study we aimed to 
 6 
quantify the extent of myocardial ischemia by documenting the transcoronary lactate 
gradient in addition to measuring troponin T values. The non-physiologic metabolism of the 
heart during aortic cross clamping may lead to myocardial injury manifested by impaired 
ventricular function and delayed recovery (11). Lactic acid concentrations have been 
extensively studied as markers of anaerobic metabolism and hypoperfusion (12,13,14,15). 
Selective sampling of coronary sinus blood may offer insight into the regional metabolic 
state of the heart which may be more profoundly affected by its dramatic alteration of 
normal blood flow than would be reflected by the systemic lactate concentration. Coronary 
sinus lactate has been used as an adjunct in the diagnosis of perioperative myocardial 
ischemia (11). 
Troponin T is the structural component of the troponin complex that binds to tropomyosin. 
The elevation of the serum concentration of troponin T begins as early as three hours after 
myocardial injury, and may persist for up to 10-14 days (16).  
Brain natriuretic peptide is predominantly released from the ventricles in response to 
myocardial stretch. and as such has been found to be instrumental in determining structural 
heart disease (9, 17). It promotes diuresis, natriuresis, arterial vasodilatation and attenuates 
the activity of the renin-angiotensin-aldosterone system (9). The frequent co-existence of 
structural heart disease and atrial fibrillation prompted us to explore the correlation between 
the N-terminal fragment of the brain natriuretic peptide (NT-pro-BNP) and AF in the patient 
population undergoing CABG. NT-pro-BNP is released when the inactive prohormone is 
split into the active brain natriuretic peptide and the inactive NT-pro-BNP.  
We hypothesized that myocardial ischemia, the inflammatory response and the presence of 
structural heart disease may influence the development of postoperative atrial fibrillation. 
The aim of our study, therefore, was to test the hypothesis that CRP, transcoronary lactate 
gradient, troponin T and NT-pro-BNP are predictors of postoperative AF.  
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MATERIALS AND METHODS 
 
Following the approval from our institutional ethics committee, 215 consecutive patients 
found to be in sinus rhythm undergoing coronary artery bypass grafting using 
cardiopulmonary bypass (CPB) were included into our study from May 2007 to May 2008. 
Informed consent was obtained from all patients. The study was conducted in a prospective 
observational fashion. Exclusion criteria were concomitant valvular pathology requiring 
surgery, reoperative surgical myocardial revascularization and prior history of atrial 
fibrillation. Patients that developed atrial fibrillation during the postoperative period 
comprised the AF group, while the remaining patients formed the SR group. Episodes of AF 
lasting for more than 10 minutes were defined as sustained AF (2, 18). Only patients in whom 
sustained AF was noted were included in the AF group. 
 
Perioperative management 
Patients receiving preoperative beta blockers were given their normal dose on the morning of 
surgery. The patients received diazepam and morphine 30 minutes prior to induction of 
anesthesia. Endotracheal tube, urinary catheter, as well as radial artery and pulmonary artery 
catheters were inserted. The anesthetic regime included induction and maintenance of 
anesthesia with midazolam, fentanyl and pancuronium bromide. This was coupled with 
sevoflurane inhalation. The initial ventilator settings included a tidal volume of 8 ml/kg, and a 
respiratory rate of 12 breaths per minute. Typically, the FiO2 was set at 50%. The critical 
components of the employed cardiopulmonary circuit were the Medtronic Affinity Trillium 
membrane oxygenator, venous reservoir and PVC tubing (Medtronic, Minneapolis, USA) and 
a Stoeckert III roller pump (Stoeckert, Munich, Germany). The ascending aorta and right 
atrium were cannulated for cardiopulmonary bypass. Myocardial protection consisted of both 
antegrade and retrograde cardioplegia. Systemic heparinization aiming at an ACT > 480 
seconds was used, followed by full reversal with protamine after decannulation. Tepid CPB 
was employed, targeting the flow at 2.2 L/min/m2. The target mean arterial pressure during 
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CPB was 60 mmHg. If necessary, norepinephrine was employed to reach the aimed blood 
pressure. The distal coronary anastomoses were performed on an arrested heart, during a 
single period of aortic cross-clamping. The lungs were open to atmosphere during CPB. 
Weaning from CPB was initiated once the patient’s rhythm had stabilized and normothermia 
had been achieved. Inotropic support was initiated in order to maintain a cardiac index greater 
than 2.2 L/min/m2.  The preferred inotropic agent was dobutamine. Norepinephrine was used 
if dobutamine produced excessive vasodilatation. Epinephrine was used if the hemodynamic 
performance remained inadequate with the previously mentioned catecholamines. An 
intraaortic balloon pump was inserted if further support was required. 
 
Measurement and Calculations 
 
The study protocol consisted of obtaining arterial blood gas samples from the radial artery 
and venous blood samples from the coronary sinus. The samples were drawn simultaneously 
by members of the surgical and anesthesiological teams. The first samples were drawn prior 
to the institution of cardiopulmonary bypass (CPB). The second and third samples were 
drawn five and ten minutes after completing the revascularization procedure, respectively. 
These raw data were then processed to obtain the transcoronary lactate gradient by subtracting 
the radial artery lactate content from the coronary sinus lactate content. Lactate levels were 
obtained using the IL Gem Premier 3000 auto-analyzer (Instrumentation Laboratory, 
Lexington, MA, USA). This analyzer uses amperometry to determine lactate concentration 
levels. It measures the current level of the analyzed blood sample after applying electrolytic 
potential, which is proportional to the analyte concentration. The initial NT-pro-BNP values 
were drawn preoperatively, as an adjunct to the standard preoperative laboratory assessment. 
The postoperative NT-pro-BNP values were drawn on the first postoperative day. NT-pro-
BNP levels were obtained using the Elecsys 2010 analyzer (Roche, Basel, Switzerland). C-
reactive protein serum concentrations were measured preoperatively, and then daily for the 
next three consecutive days. CRP levels were obtained using the Olympus AU 2700 clinical 
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chemistry platform (Olympus, Tokyo, Japan). An immunoassay method, using a general 
latex-enhanced immunoturbidimetry measurement kit was used to determine the analyte 
quantity. Troponin T levels were obtained using the Elecsys 2010 analyzer (Roche, Basel, 
Switzerland).  
 
Atrial fibrillation detection, prophylaxis and management 
All patients were continuously monitored with telemetry (Nihon Kohden WEP-4208, 
Tokyo, Japan) until postoperative day 5. A 12 lead EKG was obtained on the day prior to 
discharge. Any clinical suspicion of arrhythmia was followed by a 12 lead EKG and 
reinstitution of telemetry monitoring. Patients were routinely started on beta blockers on 
postoperative day 1 or once inotropic support has been suspended. Throughout their hospital 
stay magnesium and potassium supplements were administered in order to maintain high 
normal levels of these electrolytes. Atrial fibrillation was treated with amiodarone, sometimes 
in conjunction with electrical cardioversion.  
 
Statistical analysis 
The continuous data are presented as mean values ± standard deviation or medians with the 
interquartile range. Categorical variables are presented as absolute numbers and percentages. 
Longitudinal comparisons between samples of the same subject were analyzed using the 
Wilcoxon matched pairs test. Analyses of continuous data between different groups of 
patients were performed using the Mann-Whitney U test. Differences between categorical 
variables in patients who developed AF and those that remained in sinus rhythm were 
evaluated using Fisher’s exact test. A two tailed p value was used. A multivariate analysis of 
variables found to be significant on univariate analysis was performed using multiple linear 
regression in order to assess the independent correlates for AF. A p < 0.05 was considered to 
be of statistical significance for all deployed statistical calculations. The data were processed 
using the Statistica software package (StatSoft Inc., Tulsa, USA). 
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RESULTS 
 
Perioperative summary 
Two hundred and fifteen consecutive patients undergoing coronary artery bypass grafting 
were included into our study. The demographic data and the list of comorbidities are 
presented in Table 1.  
Fifty-five patients developed AF for an incidence of 26%. The mean time to develop AF was 
2.9 ± 2.1 days. The mean duration of AF was 15.3 ± 12.1 hours. There were no differences in 
the preoperative ejection fraction, body mass index, incidence of hypertension or severity of 
coronary artery disease between the two groups. Preoperative serum creatinine values, as well 
as, left atrial dimensions were similar between the groups. There was no difference in the 
incidence of mild valvular disease, nor was the preoperative use of antiarrhythmics, statins or 
angiotensin converting enzyme inhibitors different among the groups. Notably, the group of 
patients that developed atrial fibrillation was older (66 ± 7 vs. 60 ± 9 years,  p < 0.0001), 
more symptomatic (NYHA class 2.8 ± 0.8 vs. 2.5 ± 0.8, p = 0.03) and had a higher risk 
profile (EUROScore 3.9 ± 2.7 vs. 2.9 ± 2.2, p = 0.009). The SR group of patients had a higher 
incidence of hyperlipidemia. 
We found no difference in the duration of mechanical ventilation or the incidence of any 
major complications (Table 2). The mortality in the SR group was 1.3% (2/160), while one 
patient died in the AF group for a mortality of 1.8% (p = 1.0). The length of stay in the 
intensive care unit (ICU) was longer in the AF than the SR group (3 [3-5] vs. 2 [2-3] days, p 
< 0.0001). There were no strokes with permanent neurologic sequelae in either cohort of 
patients. One patient in the SR group had a transient ischemic event which was followed by 
prompt and complete neurologic recovery. The duration of cardiopulmonary bypass was 
longer in the AF group of patients (93 ± 30 vs. 85 ± 24 min, p = 0.05).  
Biomarker comparisons between the two groups are presented in Table 3. The mean values of 
the transcoronary lactate gradient increased from the pre-intervention value of -0.05 ± 0.37 to 
0.39 ± 0.46 mmol/L (p < 0.0001) calculated at 5 minutes after completion of the 
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revascularization procedure in the group of patients that maintained stable sinus rhythm. A 
similar increase was observed in the subgroup of patients that later developed atrial 
fibrillation where the preoperative TCLG value rose from -0.01 ± 0.27 to 0.43 ± 0.46 mmol/L 
at 5 minutes after the revascularization was complete (p < 0.0001). In both groups a trend 
towards normalizing the TCLG was seen at 10 minutes after the completion of bypass 
grafting. While the trend in longitudinal comparisons within each group was highly 
statistically significant, we found no difference between the two groups. The C-reactive 
protein serum concentration increased steadily in both groups, and peaked on postoperative 
day two. The values increased from 6 ± 13 to 163 ± 88 mg/L (p < 0.0001) and from 6 ± 16 to 
163 ± 104 mg/L (p < 0.0001)  in the SR and AF groups, respectively. No difference in the 
trends of CRP was noted between the two groups. The preoperative NT-pro-BNP 
concentration was significantly lower in the subset of patients that maintained stable sinus 
rhythm in comparison to those that went on to develop AF during the immediate 
postoperative period (273 ± 347 pg/ml in the SR group vs. 469 ± 629 pg/ml in the AF group, 
p < 0.0001). A similar relationship was observed for the postoperative NT-pro-BNP values as 
well (3111 ± 3600 pg/ml in the SR group vs. 4625 ± 5640 pg/ml in the AF group, p = 0.027). 
The longitudinal increase in the observed pre and postoperative values was highly significant 
in both groups (p < 0.0001 for both groups). The SR group of patients had a less pronounced 
enzyme leak in comparison to the AF group of patients as quantified by the serum troponin T 
values (0.67 [0.37-1.16] vs. 0.86 [0.49-2.1], p = 0.046).  
 
Multiple linear regression analysis 
Variables found to be significantly different between the AF and SR groups on univariate 
analysis were further scrutinized using the multiple linear regression analysis. The variables 
included were age, preoperative and postoperative NT-pro-BNP, troponin T, NYHA class, 
duration of CPB and EuroSCORE. We found age (p = 0.0043), preoperative NT-pro-BNP (p 
= 0.019) and duration of cardiopulmonary bypass (p = 0.035) to be significant independent 
correlates for atrial fibrillation in our population of patients on multivariate analysis. Troponin 
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T (p = 0.076), NYHA class (p = 0.058), EuroSCORE (p = 0.77) and postoperative NT-pro-
BNP (p = 0.79) were not found to be statistically significant predictors of AF.  
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DISCUSSION 
 
The pathogenesis of AF is multifactorial and may be linked to intraoperative manipulation 
with the heart, ischemia, atrial distension, inflammation and structural heart disease. Atrial 
fibrillation remains the most commonly observed arrhythmia following cardiac surgery. It 
may have profound implications on the patient's hemodynamic status as well as contribute to 
the development of thromboembolic complications inherent to the stagnation of blood within 
the dysfunctional atria. The bleeding burden brought on by the requirement for 
anticoagulation should also not be neglected. While atrial fibrillation may have a plethora of 
negative repercussions upon patient recovery, it is often self limiting and benign in its course. 
Different treatment strategies have been devised and tested in the clinical setting with the aim 
of reducing the incidence of postoperative atrial fibrillation in the cardiac surgical patient 
population. These include the administration of beta blockers, amiodarone, statins and ACE 
inhibitors (2,4,19,20,21,22). The main origin of brain natriuretic peptide is the ventricular 
myocardium, although the atria may be responsible for some of its production (23). The 
relationship between BNP and AF remains elusive. The irregularity of the rhythm may be 
responsible for uneven filling periods of the ventricle and intermittently provoke ventricular 
distention thus stimulating BNP production (23). Lactate is a sensitive marker of tissue 
acidosis. The transcoronary lactate gradient may offer more insight into the regional 
myocardial perfusion. Poor correlation of the intraoperative coronary sinus lactate and the 
postoperative serum lactate has been previously documented (11) and may indicate that the 
latter lacks sufficient sensitivity to detect subtle myocardial metabolic derangement. Whether 
there exists a relationship between CRP and atrial fibrillation is controversial (7,24). 
The aim of our study was to identify biomarkers which could prove to be useful in 
discriminating between patient populations that would develop atrial fibrillation after surgical 
coronary revascularization and those that would maintain stable sinus rhythm. We have 
demonstrated a short lived lactate washout from the heart following the revascularization 
procedure. This acute and statistically significant increase in the transcoronary lactate 
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gradient was seen in both the SR and AF group of patients. There was no significant 
variability in the TCLG between the patients that maintained sinus rhythm in comparison to 
those that developed AF. The hypothesis that the magnitude of the inflammatory response 
would influence the incidence of postoperative AF was not corroborated by the results of our 
study. While Ahlsson et al had already found that the CRP concentration measured on 
postoperative day three had no correlation with the incidence of atrial fibrillation, we 
extended our evaluation to incorporate CRP levels at three different time points.  
The serum concentration of CRP increased by a factor of 27 in both groups which was highly 
significant in a longitudinal analysis at different time points. However, there was no 
variability between the SR and AF groups at any of the studied time points. In contrast, the 
preoperative NT-pro-BNP values were very dissimilar between the patient subpopulations 
that developed AF and those that did not. The preoperative NT-pro-BNP concentration was 
significantly lower, indicating perhaps less pronounced cardiac structural abnormality, in the 
group of patients that did not develop atrial dysrhythmia. A dramatic accentuation of the NT-
pro-BNP serum concentration was observed in both groups in response to surgery. The 
postoperative values on univariate analysis were, however, significantly higher among 
patients that went on to develop AF later in their postoperative course. Our univariate analysis 
further suggested that myocardial ischemia may also play a role in the genesis of 
postoperative AF, as the AF group of patients had higher troponin T values measured on 
postoperative day one. However, multivariate analysis identified only age, preoperative NT-
pro-BNP and duration of cardiopulmonary bypass as independent predictors of AF. 
The present study has certain limitations that warrant mentioning. The patients were 
monitored up to the seventh postoperative day. Any episode of atrial fibrillation occurring 
after that day would not have been recorded and therefore not be reflected by the results of 
our study. Furthermore, the variability of the coronary sinus anatomy coupled with the fact 
that not all venous drainage from the heart enters the coronary sinus signifies that the lactate 
sample from it may not reflect all areas of the myocardium. 
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In summary, we believe that definition of algorithms that would aim to identify patients at 
higher risk for developing atrial fibrillation could select those who would benefit from more 
vigilant AF prophylaxis. The findings of our study suggest that preoperative NT-pro-BNP 
should be included into such algorithms as it was an important discriminating biomarker 
between the patient populations undergoing CABG that developed atrial fibrillation and those 
that did not.  
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Table 1. Preoperative patient characteristics 
 
 
SR group AF group p value 
N 160 55  
Age (yrs) 60±9 66±7 < 0.0001 
Gender (n/%)   0.49  
    Male 117 (73) 37 (67)  
    Female 43 (27) 18 (33)  
EUROScore 2.9±2.2 3.9±2.7 0.009 
Ejection fraction (%) 58±10  58±12 0.81  
Creatinine 96±48  96±29 0.91 
NYHA class 2.5±0.8 2.8±0.8 0.03 
Left atrial diameter (mm) 39±5 38±7 0.07 
Body mass index 29±4.9 28.1±4.1 0.08  
Hypelipidemia (n/%) 113 (70) 29 (53) 0.02 
Hypertension (n/%) 136 (85) 49 (89) 0.51  
Diabetes mellitus (n/%) 35 (22) 18 (33) 0.15  
Smoking history (n/%) 85 (53) 21 (38) 0.06  
Preop. AMI (n/%) 81 (51) 28 (51) 1.0  
Left main stenosis (n/%) 53 (33) 18 (33) 1.0  
Three vessel disease (n/%) 117 (73) 44 (80) 0.37  
Mild mitral regurgitation (n/%) 47 (29) 19 (35) 0.5 
Mild aortic stenosis (n/%) 21 (13) 6 (11) 0.82 
Preoperative medications     
     B-blockers 130 (81) 41 (75) 0.33 
     Amiodarone 9 (6) 2 (4) 0.73 
     Ca-blockers 52 (33) 24 (44) 0.14 
     ACE-I 118 (74) 36 (65) 0.3 
     Statins 141 (88) 46 (84) 0.49 
     Digoxin 2 (1) 0 (0) 1.0 
 
NYHA: New York Heart Association class; Preop. AMI: preoperative acute myocardial infarction; 
ACE-I: angiotensin converting enzyme inhibitors; Ca-blockers: calcium channel blockers 
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Table 2. Perioperative data summary 
 
 
SR group AF group p value 
No. of grafts 2.8±0.7 2.8 ±0.6 0.58  
Thrombendarterectomy (n/%) 6 (4) 4 (7) 0.28  
Ischemia (minutes)  59±19 63±21 0.17  
CPB time (minutes) 85±24 93±30 0.05    
Inotropic support (n/%) 34 (21) 18 (33) 0.1  
ICU (days)* 2 [2-3] 3 [3-5] < 0.0001 
Mechanical ventilation (hours)* 9 [8-12] 10 [8-15] 0.28  
Creatinine 103±25 114±36 0.12 
Complications (n/%)    
    Permanent stroke 0 (0) 0 (0) NS 
    TIA 1 (1) 0 (0) 1.0  
 Periop. myocardial ischemia 6 (4) 3 (5) 0.7  
    Reexploration for  bleeding 8 (5) 3 (5) 1.0  
    Acute renal failure 1 (1) 1 (2) 0.45  
    Sternal wound infection 1 (1) 0 (0) 1.0  
    IABP requirement (n/%) 9 (6) 4 (7) 0.74  
Mortality (n/%) 2 (1.3) 1 (1.8) 1.0  
 
* Data as medians and quartiles 
CPB: cardiopulmonary bypass; ICU: intensive care unit stay; TIA: transient ischemic attack; IABP: 
intraaortic balloon pump
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Table 3. Comparison of biomarkers between the SR and AF groups 
 
 SR group AF group p value  
TCLG a  -0.05±0.37 -0.01±0.27 0.93  
TCLG b  0.39±0.46 0.43±0.46 0.71  
TCLG c  0.14±0.30 0.17±0.39 0.29  
CRP d  6±13 6±16 0.22  
CRP e  88±51 87±41 0.55  
CRP f  163±88 163±104 0.44  
CRP g  137±72 149±82 0.18  
NT-pro-BNP h  273±347 469±629 <0.0001 
NT-pro-BNP i  3111±3600 4625±5640 0.027 
TnT * 0.67 [0.37-1.16] 0.86 [0.49-2.1] 0.046 
 
* Data as medians and quartiles 
TCLG: transcoronary lactate gradient (a prior to cardiopulmonary bypass, b 5 and c 10 minutes after 
cross-clamp removal); CRP: C-reactive protein (d preoperative, e postoperative day 1, f postoperative 
day 2, g postoperative day 3); NT-pro-BNP: N-terminal fragment of the brain natriuretic peptide (h 
preoperative, i  postoperative day 1), TnT: troponin T  
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